WE BRING THE CLINIC TO YOU

Get same-day appointments and access to a medical professional 24/7.

info@cometoyoumed.com
Text us: 562-661-9104

  • Working Days

    24 - 7

  • Weekend

    24 - 7

Genesis Concierge Medicine

  /  Peptides   /  GLP3 (retatrutide) and weight loss: what the research suggests

Discover the benefits of NAD+ Skin Repair Peptide therapy for healthier-looking skin and enhanced cellular energy.

Learn how NAD Injections support recovery.

Weight loss is influenced by many things, including appetite, habits, sleep, stress, health conditions, and genetics. Some people also consider medication support with a clinician. This page shares general education about weight loss and explains what researchers are studying with GLP3 (retatrutide). It is not personal medical advice.

Weight loss basics (the simple version)

  • Nutrition: A steady calorie deficit over time is usually needed for weight loss. Higher-protein, higher-fiber meals often help with fullness.
  • Movement: Activity supports health and helps maintain weight loss. Strength training can help preserve muscle.
  • Sleep and stress: Poor sleep and high stress can increase hunger and make habits harder to sustain.
  • Medical factors: Thyroid disease, PCOS, depression, binge eating, and some medications can affect weight.

Where medicines can fit

For some people, lifestyle changes alone are not enough. Clinicians may consider prescription options when appropriate. These decisions depend on your medical history, current medications, and risk factors. No medication is “right” for everyone, and side effects matter.

What is GLP3 (retatrutide)?

GLP3 (retatrutide) is an investigational medicine being studied for weight management and related metabolic conditions. It is designed to act on three receptor pathways (GIP, GLP-1, and glucagon) that are linked to appetite, blood sugar regulation, and energy balance. GLP3 (retatrutide) is investigational and is not approved for general use. (nejm.org)

What research says so far

A phase 2 trial in adults with obesity published in The New England Journal of Medicine reported meaningful average weight reduction in higher-dose study groups over 48 weeks. The same paper reported that gastrointestinal side effects were common, including nausea, diarrhea, vomiting, and constipation. Early results can be promising, but they do not replace full safety review and regulatory evaluation. (nejm.org)

Safety and “research use only” labels

GLP3 (retatrutide) affects hormone pathways, so researchers monitor side effects and broader health markers. You may also see products labeled “for research use only.” A label like that does not make something appropriate or safe for human use, and it does not replace medical supervision.

Purchase a consultation

If you want personalized guidance for weight loss, you can purchase a consultation to discuss your health history, goal  and evidence-based options with a licensed healthcare professional. This page is not a substitute for medical care, diagnosis, or treatment.

Ready to purchase?

Purchase GLP3 (retatrutide)

This page is for educational and informational purposes and is not medical advice.